4.6 Review

Systematic Review and Meta-analysis of Perioperative Outcomes and Complications After Robot-assisted Radical Prostatectomy

Journal

EUROPEAN UROLOGY
Volume 62, Issue 3, Pages 431-452

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.eururo.2012.05.044

Keywords

Prostatic neoplasms; Prostatectomy; Laparoscopy; Robotics

Funding

  1. Intuitive Surgical, Sunnyvale, CA, USA

Ask authors/readers for more resources

Context: Perioperative complications are a major surgical outcome for radical prostatectomy (RP). Objective: Evaluate complication rates following robot-assisted RP (RARP), risk factors for complications after RARP, and surgical techniques to improve complication rates after RARP. We also performed a cumulative analysis of all studies comparing RARP with retropubic RP (RRP) or laparoscopic RP (LRP) in terms of perioperative complications. Evidence acquisition: A systematic review of the literature was performed in August 2011, searching Medline, Embase, and Web of Science databases. A free-text protocol using the term radical prostatectomy was applied. The following limits were used: humans; gender (male); and publications dating from January 1, 2008. A cumulative analysis was conducted using Review Manager software v.4.2 (Cochrane Collaboration, Oxford, UK). Evidence synthesis: We retrieved 110 papers evaluating oncologic outcomes following RARP. Overall mean operative time is 152 min; mean blood loss is 166 ml; mean transfusion rate is 2%; mean catheterization time is 6.3 d; and mean in-hospital stay is 1.9d. The mean complication rate was 9%, with most of the complications being of low grade. Lymphocele/lymphorrea (3.1%), urine leak (1.8%), and reoperation (1.6%) are the most prevalent surgical complications. Blood loss (weighted mean difference: 582.77; p < 0.00001) and transfusion rate (odds ratio [OR]: 7.55; p < 0.00001) were lower in RARP than in RRP, whereas only transfusion rate (OR: 2.56; p = 0.005) was lower in RARP than in LRP. All the other analyzed parameters were similar, regardless of the surgical approach. Conclusions: RARP can be performed routinely with a relatively small risk of complications. Surgical experience, clinical patient characteristics, and cancer characteristics may affect the risk of complications. Cumulative analyses demonstrated that blood loss and transfusion rates were significantly lower with RARP than with RRP, and transfusion rates were lower with RARP than with LRP, although all other features were similar regardless of the surgical approach. (C) 2012 Published by Elsevier B.V. on behalf of European Association of Urology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

PSMA-PET and micro-ultrasound potential in the diagnostic pathway of prostate cancer

E. Lopci, G. Lughezzani, A. Castello, P. Colombo, P. Casale, A. Saita, N. M. Buffi, G. Guazzoni, A. Chiti, M. Lazzeri

Summary: In a highly-selected patient population, Ga-68-PSMA PET/CT demonstrates a higher diagnostic performance compared to PRI-MUS in the primary diagnosis of prostate cancer.

CLINICAL & TRANSLATIONAL ONCOLOGY (2021)

Article Urology & Nephrology

The Microbiome of Catheter Collected Urine in Males with Bladder Cancer According to Disease Stage

Bianca Oresta, Daniele Braga, Massimo Lazzeri, Nicola Frego, Alberto Saita, Cristina Faccani, Vittorio Fasulo, Piergiuseppe Colombo, Giorgio Guazzoni, Rodolfo Hurle, Maria Rescigno

Summary: Our study found that the urinary microbiome of male bladder cancer patients collected from catheterized urine samples is characterized by an increased abundance of Veillonella and Corynebacterium, and decreased Ruminococcus compared to controls. Different taxonomic profiles were observed in bladder washouts and midstream urines, with specific taxa showing enrichment in each sample type. These findings suggest potential diagnostic and therapeutic implications based on manipulation of the urinary microbiome.

JOURNAL OF UROLOGY (2021)

Article Oncology

Midterm follow-up (3 years) confirms and extends short-term results of intravesical gemcitabine as bladder-preserving treatment for non-muscle-invasive bladder cancer after BCG failure

Rodolfo Hurle, Roberto Contieri, Paolo Casale, Emanuela Morenghi, Alberto Saita, Nicolomaria Buffi, Giovanni Lughezzani, Piergiuseppe Colombo, Nicola Frego, Vittorio Fasulo, Marco Paciotti, Giorgio Guazzoni, Massimo Lazzeri

Summary: The study reported mid-term results of intravesical gemcitabine in non-muscle-invasive bladder cancer patients, showing a disease-free survival rate of 32.69% at 3 years. The most common adverse events were urinary symptoms and fatigue.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)

Article Urology & Nephrology

Diagnostic Accuracy of Microultrasound in Patients with a Suspicion of Prostate Cancer at Magnetic Resonance Imaging: A Single-institutional Prospective Study

Giovanni Lughezzani, Davide Maffei, Alberto Saita, Marco Paciotti, Pietro Diana, Nicolo Maria Buffi, Piergiuseppe Colombo, Grazia Maria Elefante, Rodolfo Hurle, Massimo Lazzeri, Giorgio Guazzoni, Paolo Casale

Summary: This study aimed to evaluate the accuracy of microultrasound in diagnosing clinically significant prostate cancer, finding that microultrasound has high sensitivity but low specificity in the diagnosis of csPCa.

EUROPEAN UROLOGY FOCUS (2021)

Article Cell Biology

Mitochondrial metabolic reprogramming controls the induction of immunogenic cell death and efficacy of chemotherapy in bladder cancer

Bianca Oresta, Chiara Pozzi, Daniele Braga, Rodolfo Hurle, Massimo Lazzeri, Piergiuseppe Colombo, Nicola Frego, Marco Erreni, Cristina Faccani, Grazia Elefante, Matteo Barcella, Giorgio Guazzoni, Maria Rescigno

Summary: The study revealed the mechanism by which Mitomycin C promotes immunogenic cell death, relying on metabolic reprogramming of tumor cells towards increased oxidative phosphorylation. This finding offers opportunities to optimize bladder cancer management and provides potential markers of treatment efficacy.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Urology & Nephrology

Management of patients who opt for radical prostatectomy during the coronavirus disease 2019 (COVID-19) pandemic: an international accelerated consensus statement

Zafer Tandogdu, Justin Collins, Greg Shaw, Jennifer Rohn, Bela Koves, Ashwin Sachdeva, Ahmed Ghazi, Alexander Haese, Alex Mottrie, Anup Kumar, Ananthakrishnan Sivaraman, Ashutosh Tewari, Benjamin Challacombe, Bernardo Rocco, Camilo Giedelman, Christian Wagner, Craig G. Rogers, Declan G. Murphy, Dmitry Pushkar, Gabriel Ogaya-Pinies, James Porter, Kulthe Ramesh Seetharam, Markus Graefen, Marcelo A. Orvieto, Marcio Covas Moschovas, Oscar Schatloff, Peter Wiklund, Rafael Coelho, Rair Valero, Theo M. de Reijke, Thomas Ahlering, Travis Rogers, Henk G. van der Poel, Vipul Patel, Walter Artibani, Florian Wagenlehner, Kris Maes, Koon H. Rha, Senthil Nathan, Truls Erik Bjerklund Johansen, Peter Hawkey, John Kelly

Summary: This study aims to provide guidance on prioritization and management pathways for patients with non-metastatic prostate cancer experiencing delays in surgical treatment and identify ways to reduce infection risk during the COVID-19 pandemic. Recommendations were made for reconfiguring prostate cancer pathways and implementing infection prevention and control measures to ensure low likelihood of nosocomial COVID-19 for surgical patients.

BJU INTERNATIONAL (2021)

Article Urology & Nephrology

Feasibility, safety, and efficacy of ultrasound-guided transperineal laser ablation for the treatment of benign prostatic hyperplasia: a single institutional experience

Nicola Frego, Alberto Saita, Paolo Casale, Pietro Diana, Roberto Contieri, Pier Paolo Avolio, Massimo Lazzeri, Rodolfo Hurle, Nicolo Maria Buffi, Giorgio Ferruccio Guazzoni, Giovanni Lughezzani

Summary: Ultrasound-guided transperineal laser ablation (TPLA) seems to be a promising minimally invasive surgical therapy for treating lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). The procedure was well tolerated by patients, resulting in significant reductions in prostate volume and improvements in IPSS scores and maximal flow rate at 3, 6, and 12 months post-operation follow-up. Further long-term results and comparative studies are needed to fully assess its effectiveness compared to standard treatments.

WORLD JOURNAL OF UROLOGY (2021)

Article Urology & Nephrology

Outcomes in robot-assisted partial nephrectomy for imperative vs elective indications

Jo-Lynn S. Tan, Niranjan Sathianathen, Marcus Cumberbatch, Prokar Dasgupta, Alexandre Mottrie, Ronney Abaza, Koon Ho Rha, Thyavihally B. Yuvaraja, Dipen J. Parekh, Umberto Capitanio, Rajesh Ahlawat, Sudhir Rawal, Nicolo M. Buffi, Ananthakrishnan Sivaraman, Kris K. Maes, Gagan Gautham, Francesco Porpiglia, Levent Turkeri, Mahendra Bhandari, Benjamin Challacombe, James Roscoe Porter, Craig R. Rogers, Daniel A. Moon

Summary: The study compared peri-operative outcomes of patients undergoing robot-assisted partial nephrectomy for imperative vs elective indications. No significant differences were found in ischaemia time, operating time, estimated blood loss, rate of blood transfusions, or Clavien-Dindo complications between the two groups. However, a greater decrease in postoperative estimated glomerular filtration rate was observed in the imperative indication group.

BJU INTERNATIONAL (2021)

Article Oncology

Oncofid-P-B: a novel treatment for BCG unresponsive carcinoma in situ (CIS) of the bladder: Results of a prospective European Multicentre study at 15 months from treatment start

Rodolfo Hurle, Giorgio Guazzoni, Piergiuseppe Colombo, Armando Santoro, Ottavio De Cobelli, Ettore Di Trapani, Gloria Nohales, Llorente Carlos, Ramon Duran-Merino, Massimo Lazzeri

Summary: This study evaluates the safety and efficacy of Oncofid-P-B in CIS patients who are unresponsive or intolerant to BCG, showing a 75% complete response rate after 12 weeks of treatment and a 40% complete response rate still after 15 months. Only 7 drug-related adverse events were reported, with drug concentrations below the limit of quantification in all plasma samples.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2022)

Article Urology & Nephrology

Use of high-resolution micro-ultrasound to predict extraprostatic extension of prostate cancer prior to surgery: a prospective single-institutional study

Vittorio Fasulo, Nicolo Maria Buffi, Federica Regis, Marco Paciotti, Fancesco Persico, Davide Maffei, Alessandro Uleri, Alberto Saita, Paolo Casale, Rodolfo Hurle, Massimo Lazzeri, Giorgio Guazzoni, Giovanni Lughezzani

Summary: This study evaluated the accuracy of micro-ultrasound in predicting extraprostatic extension of Prostate Cancer prior to surgery. The results showed that micro-ultrasound can accurately predict extraprostatic extension at the final pathology report in patients scheduled for robot-assisted radical prostatectomy.

WORLD JOURNAL OF UROLOGY (2022)

Article Oncology

Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under Active Surveillance for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study

Vittorio Fasulo, Marco Paciotti, Massimo Lazzeri, Roberto Contieri, Paolo Casale, Alberto Saita, Giovanni Lughezzani, Pietro Diana, Nicola Frego, Pier Paolo Avolio, Piergiuseppe Colombo, Grazia Maria Elefante, Giorgio Guazzoni, Nicolo Maria Buffi, Michael Bates, Rodolfo Hurle

Summary: The study found that longitudinally repeating the Xpert BC Monitor assay can significantly reduce the number of unnecessary cystoscopies and urine cytology during follow-up.

FRONTIERS IN ONCOLOGY (2022)

Article Oncology

Head-to-Head Comparison between High-Resolution Microultrasound Imaging and Multiparametric MRI in Detecting and Local Staging of Bladder Cancer: The BUS-MISS Protocol

Pietro Diana, Giovanni Lughezzani, Alberto Saita, Alessandro Uleri, Nicola Frego, Roberto Contieri, Nicolomaria Buffi, Luca Balzarini, Federico D'Orazio, Colombo Piergiuseppe, Maria Grazia Elefante, Massimo Lazzeri, Giorgio Guazzoni, Paolo Casale, Rodolfo Hurle

Summary: This study compared the diagnostic accuracy of 29-MHz high-resolution micro-ultrasound (mUS) and magnetic resonance imaging (MRI) in differentiating non-muscle invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC). The results showed that mUS had a better performance in distinguishing NMIBC from MIBC. However, the main limitation of mUS was its probe shape, which made its use problematic in cases with a large prostate and inadequate rectal preparation.

BLADDER CANCER (2022)

Article Surgery

External Validation and Comparison of Two Nomograms Predicting the Probability of Lymph Node Involvement in Patients subjected to Robot-Assisted Radical Prostatectomy and Concomitant Lymph Node Dissection: A Single Tertiary Center Experience in the MRI-Era

Nicola Frego, Marco Paciotti, Nicolo Maria Buffi, Davide Maffei, Roberto Contieri, Pier Paolo Avolio, Vittorio Fasulo, Alessandro Uleri, Massimo Lazzeri, Rodolfo Hurle, Alberto Saita, Giorgio Ferruccio Guazzoni, Paolo Casale, Giovanni Lughezzani

Summary: In this study, the performance of the Briganti 2012 and Briganti 2019 nomograms in predicting lymph node invasion (LNI) was externally validated and compared. The results showed that the updated Briganti 2019 nomogram, which included MRI and MRI-targeted biopsy data, was not significantly more accurate than the 2012 model in predicting LNI. This suggests a negligible role of mpMRI in the current population.

FRONTIERS IN SURGERY (2022)

Article Oncology

Long-term Follow-up and Factors Associated with Active Surveillance Failure for Patients with Non-muscle-invasive Bladder Cancer: The Bladder Cancer Italian Active Surveillance (BIAS) Experience

Roberto Contieri, Marco Paciotti, Giovanni Lughezzani, Nicolo M. Buffi, Nicola Frego, Pietro Diana, Vittorio Fasulo, Alberto Saita, Paolo Casale, Massimo Lazzeri, Giorgio Guazzoni, Rodolfo Hurle

Summary: This study reports the long-term results and factors associated with failure in patients undergoing active surveillance for recurrent low-risk non-muscle-invasive bladder cancer. The findings suggest that well-selected patients with low-grade tumors can safely undergo active surveillance for an extended period, while multiple transurethral resections and multiple lesions at enrollment are associated with a higher risk of failure.

EUROPEAN UROLOGY ONCOLOGY (2022)

Article Urology & Nephrology

Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy

Massimo Lazzeri, Stefano Duga, Elena Azzolini, Vittorio Fasulo, Nicolo Buffi, Alberto Saita, Giovanni Lughezzani, Elvezia M. Paraboschi, Rodolfo Hurle, Alessandro Nobili, Maurizio Cecconi, Giorgio Guazzoni, Paolo Casale, Rosanna Asselta

Summary: This study compared the hospitalization rates for COVID-19 between males exposed to 5ARIs and a control group, and found that males exposed to 5ARIs had a lower risk of hospitalization. This suggests the potential protective effect of 5ARIs against severe COVID-19.

MINERVA UROLOGY AND NEPHROLOGY (2022)

No Data Available